Potential Impacts of the Federal Reclassification of Marijuana

[co-author: Crystal Singh] In May, President Biden announced the Drug Enforcement Administration (DEA)’s proposed rule reclassifying marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act (CSA). Schedule I classification is reserved for substances with a high potential for abuse and no accepted medical usage—such as heroin, ecstasy, and LSD—and thus […]